Ameriprise Financial Inc Verve Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 226,056 shares of VERV stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

226,056

Previous 179,418 25.99%

Holding current value

$1.25 Million

Previous $875,000 25.03%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.4 - $7.86 $205,207 - $366,574	46,638 Added 25.99%	226,056 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$4.76 - $12.79 $378,220 - $1.02 Million	79,458 Added 79.49%	179,418 $875,000
Q1 2024 May 15, 2024	SELL	$10.81 - $17.96 $40,137 - $66,685	-3,713 Reduced 3.58%	99,960 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $368,124 - $778,724	41,643 Added 67.13%	103,673 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $159,971 - $291,646	14,008 Added 29.17%	62,030 $822,000
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $120,566 - $179,856	-9,038 Reduced 15.84%	48,022 $900,000
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $225,453 - $378,541	15,766 Added 38.18%	57,060 $822,000
Q4 2022 Feb 14, 2023	SELL	$17.85 - $40.7 $41,322 - $94,220	-2,315 Reduced 5.31%	41,294 $799,000
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $29,603 - $78,582	1,894 Added 4.54%	43,609 $1.5 Million
Q2 2022 Aug 15, 2022	BUY	$11.14 - $23.17 $116,546 - $242,404	10,462 Added 33.48%	41,715 $637,000
Q1 2022 May 16, 2022	BUY	$20.92 - $39.36 $68,094 - $128,116	3,255 Added 11.63%	31,253 $713,000
Q4 2021 Feb 14, 2022	SELL	$31.94 - $54.82 $19,483 - $33,440	-610 Reduced 2.13%	27,998 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $106,996 - $172,100	2,326 Added 8.85%	28,608 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$31.92 - $60.25 $838,921 - $1.58 Million	26,282 New	26,282 $1.58 Million

Others Institutions Holding VERV

# of Institutions

185

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $331M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Verve Therapeutics, Inc. Transaction History